Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification

Diego Brancaccio1, Antonio Bellasi, Mario Cozzolino

  • 1Department of Nephrology, San Paolo Hospital, University of Milan, Italy. diego.brancaccio@ tiscalinet.it

Insights

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) involves abnormal bone and mineral metabolism, leading to vascular calcification (VC) and increased mortality. Current strategies focus on managing calcium, phosphate, and parathyroid hormone levels to prevent VC progression.

Area of Science:

  • Nephrology
  • Endocrinology
  • Pathology

Background:

  • Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) is a complex condition affecting mineral and bone metabolism in CKD patients.
  • CKD-MBD is characterized by serum calcium and phosphate imbalances, altered bone turnover, and vascular calcification (VC).
  • VC in uremic patients shares similarities with bone mineralization, suggesting a biological link to mineral derangements and increased mortality.

Purpose of the Study:

  • To review the current understanding of vascular calcification (VC) in Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD).
  • To summarize evidence-based strategies for preventing and treating VC in CKD patients.
  • To highlight the link between VC and increased mortality in CKD-MBD.

Main Methods:

  • Review of current literature on CKD-MBD and vascular calcification.
  • Analysis of the biological processes underlying VC in CKD.
  • Synthesis of evidence supporting current treatment modalities for VC.

Main Results:

  • Vascular calcification begins in early CKD stages and is prevalent in advanced stages (CKD-3, -4, -5).
  • The presence and extent of VC are associated with poor prognosis in CKD patients.
  • VC is an active biological process analogous to bone mineralization.

Conclusions:

  • Effective management of calcium, phosphate, and parathyroid hormone is crucial in CKD-MBD.
  • Utilizing calcium-free phosphate binders and vitamin D analogs are key therapeutic strategies.
  • These interventions aim to improve quality of life and reduce mortality in CKD patients by mitigating VC.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...